These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 23580407)
1. Frequent DNA methylation of MiR-129-2 and its potential clinical implication in hepatocellular carcinoma. Lu CY; Lin KY; Tien MT; Wu CT; Uen YH; Tseng TL Genes Chromosomes Cancer; 2013 Jul; 52(7):636-43. PubMed ID: 23580407 [TBL] [Abstract][Full Text] [Related]
2. Methylation-associated silencing of microRNA-34b in hepatocellular carcinoma cancer. Xie K; Liu J; Chen J; Dong J; Ma H; Liu Y; Hu Z Gene; 2014 Jun; 543(1):101-7. PubMed ID: 24704024 [TBL] [Abstract][Full Text] [Related]
3. miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma. Furuta M; Kozaki KI; Tanaka S; Arii S; Imoto I; Inazawa J Carcinogenesis; 2010 May; 31(5):766-76. PubMed ID: 19843643 [TBL] [Abstract][Full Text] [Related]
4. [Aberrant methylation of multiple genes and its clinical implication in hepatocellular carcinoma]. Lou C; Yang B; Gao YT; Wang YJ; Nie FH; Yuan Q; Zhang CL; Du Z Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):831-6. PubMed ID: 19173828 [TBL] [Abstract][Full Text] [Related]
6. Hepatic miR-126 is a potential plasma biomarker for detection of hepatitis B virus infected hepatocellular carcinoma. Ghosh A; Ghosh A; Datta S; Dasgupta D; Das S; Ray S; Gupta S; Datta S; Chowdhury A; Chatterjee R; Mohapatra SK; Banerjee S Int J Cancer; 2016 Jun; 138(11):2732-44. PubMed ID: 26756996 [TBL] [Abstract][Full Text] [Related]
7. Plasma miRNAs as early biomarkers for detecting hepatocellular carcinoma. Wen Y; Han J; Chen J; Dong J; Xia Y; Liu J; Jiang Y; Dai J; Lu J; Jin G; Han J; Wei Q; Shen H; Sun B; Hu Z Int J Cancer; 2015 Oct; 137(7):1679-90. PubMed ID: 25845839 [TBL] [Abstract][Full Text] [Related]
8. Metastasis-related miR-185 is a potential prognostic biomarker for hepatocellular carcinoma in early stage. Zhi Q; Zhu J; Guo X; He S; Xue X; Zhou J; Hu B; Li H; Chen S; Zhao H; Kuang Y Biomed Pharmacother; 2013 Jun; 67(5):393-8. PubMed ID: 23648054 [TBL] [Abstract][Full Text] [Related]
9. MicroRNA-148a is silenced by hypermethylation and interacts with DNA methyltransferase 1 in hepatocellular carcinogenesis. Long XR; He Y; Huang C; Li J Int J Oncol; 2014 Jun; 44(6):1915-22. PubMed ID: 24714841 [TBL] [Abstract][Full Text] [Related]
10. Serum microRNA-1 and microRNA-122 are prognostic markers in patients with hepatocellular carcinoma. Köberle V; Kronenberger B; Pleli T; Trojan J; Imelmann E; Peveling-Oberhag J; Welker MW; Elhendawy M; Zeuzem S; Piiper A; Waidmann O Eur J Cancer; 2013 Nov; 49(16):3442-9. PubMed ID: 23810247 [TBL] [Abstract][Full Text] [Related]
11. Downregulation of DENND2D by promoter hypermethylation is associated with early recurrence of hepatocellular carcinoma. Kanda M; Nomoto S; Oya H; Takami H; Hibino S; Hishida M; Suenaga M; Yamada S; Inokawa Y; Nishikawa Y; Asai M; Fujii T; Sugimoto H; Kodera Y Int J Oncol; 2014 Jan; 44(1):44-52. PubMed ID: 24189587 [TBL] [Abstract][Full Text] [Related]
12. Down-regulated microRNA-152 induces aberrant DNA methylation in hepatitis B virus-related hepatocellular carcinoma by targeting DNA methyltransferase 1. Huang J; Wang Y; Guo Y; Sun S Hepatology; 2010 Jul; 52(1):60-70. PubMed ID: 20578129 [TBL] [Abstract][Full Text] [Related]
13. Deregulation of miR-92a expression is implicated in hepatocellular carcinoma development. Shigoka M; Tsuchida A; Matsudo T; Nagakawa Y; Saito H; Suzuki Y; Aoki T; Murakami Y; Toyoda H; Kumada T; Bartenschlager R; Kato N; Ikeda M; Takashina T; Tanaka M; Suzuki R; Oikawa K; Takanashi M; Kuroda M Pathol Int; 2010 May; 60(5):351-7. PubMed ID: 20518884 [TBL] [Abstract][Full Text] [Related]
14. Low mir-372 expression correlates with poor prognosis and tumor metastasis in hepatocellular carcinoma. Wu G; Wang Y; Lu X; He H; Liu H; Meng X; Xia S; Zheng K; Liu B BMC Cancer; 2015 Mar; 15():182. PubMed ID: 25880458 [TBL] [Abstract][Full Text] [Related]
15. [Expression of serum microRNAs (miR-222, miR-181, miR-216) in human hepatocellular carcinoma and its clinical significance]. Zhan MX; Li Y; Hu BS; Shao PJ; Meng QW; He X; Huang JW; Lu LG Zhonghua Yi Xue Za Zhi; 2013 Jun; 93(23):1830-2. PubMed ID: 24124720 [TBL] [Abstract][Full Text] [Related]
16. Aberrant DNA methylation profile and frequent methylation of KLK10 and OXGR1 genes in hepatocellular carcinoma. Lu CY; Hsieh SY; Lu YJ; Wu CS; Chen LC; Lo SJ; Wu CT; Chou MY; Huang TH; Chang YS Genes Chromosomes Cancer; 2009 Dec; 48(12):1057-68. PubMed ID: 19760608 [TBL] [Abstract][Full Text] [Related]
17. Epigenetic repression of miR-132 expression by the hepatitis B virus x protein in hepatitis B virus-related hepatocellular carcinoma. Wei X; Tan C; Tang C; Ren G; Xiang T; Qiu Z; Liu R; Wu Z Cell Signal; 2013 May; 25(5):1037-43. PubMed ID: 23376496 [TBL] [Abstract][Full Text] [Related]
18. MicroRNA-520e suppresses growth of hepatoma cells by targeting the NF-κB-inducing kinase (NIK). Zhang S; Shan C; Kong G; Du Y; Ye L; Zhang X Oncogene; 2012 Aug; 31(31):3607-20. PubMed ID: 22105365 [TBL] [Abstract][Full Text] [Related]
19. MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo. He XX; Chang Y; Meng FY; Wang MY; Xie QH; Tang F; Li PY; Song YH; Lin JS Oncogene; 2012 Jul; 31(28):3357-69. PubMed ID: 22056881 [TBL] [Abstract][Full Text] [Related]
20. The regulation of microRNA expression by DNA methylation in hepatocellular carcinoma. He XX; Kuang SZ; Liao JZ; Xu CR; Chang Y; Wu YL; Gong J; Tian DA; Guo AY; Lin JS Mol Biosyst; 2015 Feb; 11(2):532-9. PubMed ID: 25424171 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]